Last checked at 
LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning and Thursday afternoon:
----------
FTSE 100
----------
SOCGEN RAISES BT GROUP TO 'BUY' ('HOLD') - PRICE TARGET 480 (245) PENCE
----------
NUMIS CUTS RANDGOLD RESOURCES TO 'HOLD' ('BUY') - TARGET 5200 (4900) PENCE
----------
NUMIS CUTS ANTOFAGASTA TO 'REDUCE' ('HOLD') - TARGET 600 (700) PENCE
----------
S&P CAPITAL IQ RAISES ASSOCIATED BRITISH FOODS PRICE TARGET TO 2500 (2250) PENCE; LEAVES AT 'STRONG SELL'
----------
GOLDMAN CUTS BRITISH AMERICAN TOBACCO PRICE TARGET TO 3142 (3150) PENCE - 'SELL'
----------
GOLDMAN CUTS DIAGEO PRICE TARGET TO 1865 (1930) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE RAISES INTERNATIONAL AIRLINES GROUP PRICE TARGET TO 678 (654) PENCE - 'OUTPERFORM'
----------
TRADERS: NOMURA CUTS PRICE TARGET BRITISH AMERICAN TOBACCO TO 2870 (4060) PENCE
----------
TRADERS: NOMURA RAISES IMPERIAL TOBACCO PRICE TARGET TO 2510 (2490) PENCE
----------
MORGAN STANLEY RAISES IMPERIAL TOBACCO PRICE TARGET TO 3250 (2680) PENCE - 'OVERWEIGHT'
----------
TRADERS: NOMURA RAISES EXPERIAN PRICE TARGET TO 1215 (1200) PENCE
----------
BARCLAYS CUTS SHIRE TO 'EQUAL WEIGHT' ('OVERWEIGHT') - TARGET 5000 (4535) PENCE
----------
BARCLAYS CUTS ASTRAZENECA TO 'UNDERWEIGHT' ('EQUAL WEIGHT')
----------
BARCLAYS CUTS ASTRAZENECA PRICE TARGET TO 4600 (4400) PENCE
----------
BARCLAYS RAISES GLAXOSMITHKLINE PRICE TARGET TO 1700 (1600) PENCE - 'OVERWEIGHT'
----------
BARCLAYS CUTS TULLOW OIL PRICE TARGET TO 550 (600) PENCE - 'OVERWEIGHT'
----------
TRADERS: INVESTEC RAISES RBS TO 'HOLD' ('SELL')
----------
BARCLAYS RAISES BARRATT DEVELOPMENTS TARGET TO 507.3 (501.2) P - 'OVERWEIGHT'
----------
GOLDMAN RAISES BARRATT DEVELOPMENTS PRICE TARGET TO 502 (500) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES SABMILLER PRICE TARGET TO 3900 (3850) PENCE - 'BUY'
----------
FTSE 250
----------
SHORE CAPITAL CUTS PROVIDENT FINANCIAL TO 'HOLD' ('BUY') - TARGET 2350 PENCE
----------
SOCGEN RAISES HOME RETAIL PRICE TARGET TO 162 (156) PENCE - 'SELL'
----------
SOCGEN INITIATES TALK TALK TELECOM WITH 'HOLD' - TARGET 320 PENCE
----------
GOLDMAN SACHS RAISES TALK TALK TELECOM TO 'BUY' ('NEUTRAL') - TARGET 520.0 (474.4) PENCE
----------
BARCLAYS CUTS COUNTRYWIDE TO 'EQUAL WEIGHT' ('OVERWEIGHT')
----------
BARCLAYS CUTS COUNTRYWIDE PRICE TARGET TO 488.5 (524.8) PENCE
----------
BARCLAYS CUTS AFREN PRICE TARGET TO 28 (50) PENCE - 'UNDERWEIGHT'
----------
Investec Raises JD Sports Fashion Price Target To 610P, Keeps At Buy
----------
Cantor Fitzgerald Raises JD Sports Fashion Target To 550P, Keeps Buy
----------
GOLDMAN CUTS BOVIS HOMES PRICE TARGET TO 1177 (1214) PENCE - 'BUY'
----------
GOLDMAN CUTS BRITVIC PRICE TARGET TO 820 (830) PENCE - 'BUY'
----------
GOLDMAN RAISES ICAP PRICE TARGET TO 455 (395) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES JUST EAT PRICE TARGET TO 425 (400) PENCE - 'BUY'
----------
GOLDMAN CUTS PZ CUSSONS PRICE TARGET TO 375 (415) PENCE - 'BUY'
----------
MAIN MARKET AND AIM
----------
Numis Cuts MyCelx To Add From Buy, Price Target To 207P From 400P
----------
NUMIS CUTS MINERA IRL PRICE TARGET TO 10 (15) PENCE - 'BUY'
----------
NUMIS CUTS POLAR CAPITAL PRICE TARGET TO 420 (430) PENCE - 'HOLD'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2015 Alliance News Limited. All Rights Reserved.
Today 19:57
GSK knew about Zantac cancer risk, attorneys tell jury in first trial
May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.
Read more